Evidence map›Paper›PMID 21281464›Full record

ArticleBMC public health2011

Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care.

Isabel Del-Cura González, Francisca García-de-Blas González, Teresa Sanz Cuesta, Jesús Martín Fernández, Justo M Del-Alamo Rodríguez, Rosa A Escriva Ferrairo, M Del Canto De-Hoyos Alonso, Laura Balsalobre Arenas, Ricardo Rodríguez Barrientos, Elisa Ceresuela Wiesmann and 22 more

Abstract readMulticenter Study
In one paragraph

Article in BMC public health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Identification and pattern of antifungal susceptibility ofIranian journal of microbiology · 2023
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Isabel Del-Cura GonzálezUnidad de Investigación, Atención Primaria Area 9, Servicio Madrileño de Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, Spain. icura.gapm09@salud.madrid.org.
Francisca García-de-Blas González
Teresa Sanz Cuesta
Jesús Martín Fernández
Justo M Del-Alamo Rodríguez
Rosa A Escriva Ferrairo
M Del Canto De-Hoyos Alonso
Laura Balsalobre Arenas
Ricardo Rodríguez Barrientos
Elisa Ceresuela Wiesmann
Cristina De-Alba Romero
Yolanda Ginés Díaz
Ana Pastor Rodríguez-Moñino
Blanca Gutiérrez Teira
Marta Sánchez-Celaya Del Pozo
Jesús Fernández Horcajuelo
María J Rojas Giraldo
Paulino Cubero González
Rocío A Vello Cuadrado
Beatriz López Uriarte
Jeannet Sánchez Yepes
Yolanda Hernando Sanz
M José Iglesias Piñeiro
Susana Tudanca Hernández
Fernando Gallardo Alonso
Ana I González González
Alicia Simón Fernández
Carmen Carballo
Ana Rey López
Fernanda Morales
Dolores Martínez López
GRUPO PRESEVAC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies associated with the report of the preferred way that limit the use of such data. Risk factors associated with recurrent vulvovaginal candidiasis still remain controversial. METHODS/

designThis work describes a protocol of a multicentric prospective observational study with one year follow up, to describe the women's reasons and preferences to choose the way of administration (oral vs topical) in the treatment of not complicated candidal vaginitis. The number of women required is 765, they are chosen by consecutive sampling. All of whom are aged 16 and over with vaginal discharge and/or vaginal pruritus, diagnosed with not complicated vulvovaginitis in Primary Care in Madrid.The main outcome variable is the preferences of the patients in treatment choice; secondary outcome variables are time to symptoms relief and adverse reactions and the frequency of recurrent vulvovaginitis and the risk factors. In the statistical analysis, for the main objective will be descriptive for each of the variables, bivariant analysis and multivariate analysis (logistic regression).. The dependent variable being the type of treatment chosen (oral or topical) and the independent, the variables that after bivariant analysis, have been associated to the treatment preference. DISCUSSION: Clinical decisions, recommendations, and practice guidelines must not only attend to the best available evidence, but also to the values and preferences of the informed patient.

Indexed as

Patient PreferencePrimary Health CareSafetyAdministration, OralAdministration, TopicalAdolescentAdultAntifungal AgentsCandidiasis, VulvovaginalFemaleHumansMiddle AgedProspective StudiesYoung AdultAntifungal Agents

Identifiers

PMID21281464
PMCPMC3048533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.